ALDH1A1 and breast cancer: In this retrospective study, to evaluate the potential of CD133 or ALDH1 as a surrogate marker for NAC resistance, we examined the correlation between chemosensitivity to NAC and CD133 or ALDH1 as well as prognosis of patients with breast cancer after NAC treatment.